EP1144377A4 - Derives d'oxetanone - Google Patents

Derives d'oxetanone

Info

Publication number: EP1144377A4
Authority: EP; European Patent Office
Prior art keywords: oxetanone; derivatives; oxetanone derivatives
Prior art date: 1999-10-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00973938A

Other languages

German (de)

English (en)

Other versions

EP1144377A1 (fr

Inventor

John Jason Gentry Mullins

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-29

Filing date

2000-10-27

Publication date

2002-05-02

1999-10-29 Priority claimed from US09/431,551 external-priority patent/US6235305B1/en

2000-10-27 Application filed by Individual filed Critical Individual

2001-10-17 Publication of EP1144377A1 publication Critical patent/EP1144377A1/fr

2002-05-02 Publication of EP1144377A4 publication Critical patent/EP1144377A4/fr

Status Withdrawn legal-status Critical Current

Links

VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical class O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

EP00973938A 1999-10-29 2000-10-27 Derives d'oxetanone Withdrawn EP1144377A4 (fr)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US165960		1998-10-01
US09/431,551 US6235305B1 (en)	1999-10-29	1999-10-29	Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
US431551		1999-10-29
US16596099P	1999-11-17	1999-11-17
US61832800A	2000-07-18	2000-07-18
US618328		2000-07-18
PCT/US2000/029641 WO2001032616A2 (fr)	1999-10-29	2000-10-27	Derives d'oxetanone

Publications (2)

Publication Number	Publication Date
EP1144377A1 EP1144377A1 (fr)	2001-10-17
EP1144377A4 true EP1144377A4 (fr)	2002-05-02

Family

ID=27389199

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00973938A Withdrawn EP1144377A4 (fr)	1999-10-29	2000-10-27	Derives d'oxetanone

Country Status (8)

Country	Link
EP (1)	EP1144377A4 (fr)
JP (1)	JP2003524685A (fr)
CN (1)	CN1342169A (fr)
AU (2)	AU1347701A (fr)
CA (1)	CA2358921A1 (fr)
IL (1)	IL144045A0 (fr)
MX (1)	MXPA01006755A (fr)
WO (2)	WO2001032616A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030027786A1 (en)	2001-06-06	2003-02-06	Karsten Maeder	Lipase inhibiting composition
US6730319B2 (en)	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
DE102004009076A1 (de) *	2004-02-23	2005-10-27	Solvay Pharmaceuticals Gmbh	Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7074822B2 (en)	2004-02-23	2006-07-11	Solvay Pharmaceuticals Gmbh	Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4931463A (en) *	1984-12-21	1990-06-05	Hoffmann-La Roche Inc.	Oxetanones
US4983746A (en) *	1984-12-21	1991-01-08	Hoffmann-La Roche Inc.	Oxetanones and process for their production
EP0444482A2 (fr) *	1990-02-26	1991-09-04	F. Hoffmann-La Roche Ag	Oxetanones
US5246960A (en) *	1984-12-21	1993-09-21	Hoffmann-La Roche Inc.	Oxetanones
EP0638317A1 (fr) *	1993-08-05	1995-02-15	F. Hoffmann-La Roche Ag	Composition pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS608117B2 (ja) *	1977-02-08	1985-02-28	財団法人微生物化学研究会	新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) *	1978-05-25	1982-07-28	Microbial Chem Res Found	Physiologically active derivatives of esterastin and production thereof

2000
- 2000-10-27 WO PCT/US2000/029641 patent/WO2001032616A2/fr not_active Ceased
- 2000-10-27 CA CA002358921A patent/CA2358921A1/fr not_active Abandoned
- 2000-10-27 AU AU13477/01A patent/AU1347701A/en not_active Abandoned
- 2000-10-27 IL IL14404500A patent/IL144045A0/xx unknown
- 2000-10-27 MX MXPA01006755A patent/MXPA01006755A/es unknown
- 2000-10-27 AU AU12381/01A patent/AU1238101A/en not_active Abandoned
- 2000-10-27 JP JP2001534769A patent/JP2003524685A/ja active Pending
- 2000-10-27 WO PCT/US2000/029592 patent/WO2001032670A1/fr not_active Ceased
- 2000-10-27 CN CN00804391A patent/CN1342169A/zh active Pending
- 2000-10-27 EP EP00973938A patent/EP1144377A4/fr not_active Withdrawn

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4931463A (en) *	1984-12-21	1990-06-05	Hoffmann-La Roche Inc.	Oxetanones
US4983746A (en) *	1984-12-21	1991-01-08	Hoffmann-La Roche Inc.	Oxetanones and process for their production
US5175186A (en) *	1984-12-21	1992-12-29	Hoffmann-La Roche Inc.	Oxetanones
US5246960A (en) *	1984-12-21	1993-09-21	Hoffmann-La Roche Inc.	Oxetanones
EP0444482A2 (fr) *	1990-02-26	1991-09-04	F. Hoffmann-La Roche Ag	Oxetanones
EP0638317A1 (fr) *	1993-08-05	1995-02-15	F. Hoffmann-La Roche Ag	Composition pharmaceutique

Also Published As

Publication number	Publication date
JP2003524685A (ja)	2003-08-19
CN1342169A (zh)	2002-03-27
AU1238101A (en)	2001-05-14
AU1347701A (en)	2001-05-14
CA2358921A1 (fr)	2001-05-10
MXPA01006755A (es)	2003-05-15
WO2001032670A1 (fr)	2001-05-10
WO2001032616A3 (fr)	2002-01-10
EP1144377A1 (fr)	2001-10-17
WO2001032616A2 (fr)	2001-05-10
IL144045A0 (en)	2002-04-21

Legal Events

Date	Code	Title	Description
2001-08-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-10-17	17P	Request for examination filed	Effective date: 20010724
2001-10-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-10-17	AX	Request for extension of the european patent	Free format text: AL PAYMENT 20010724;LT PAYMENT 20010724;LV PAYMENT 20010724;MK PAYMENT 20010724;RO PAYMENT 20010724;SI PAYMENT 20010724
2002-03-27	D17D	Deferred search report published (deleted)
2002-03-27	RIC1	Information provided on ipc code assigned before grant	Free format text: 7C 08B 37/08 A
2002-05-02	A4	Supplementary search report drawn up and despatched	Effective date: 20020318
2002-05-02	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-05-02	RIC1	Information provided on ipc code assigned before grant	Free format text: 7C 08B 37/08 A, 7A 61K 31/715 B, 7A 61P 3/04 B
2005-09-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-11-09	18D	Application deemed to be withdrawn	Effective date: 20050104

Publication	Publication Date	Title
EG23817A (en)	2007-09-19	4-Phenyl-pyridine derivatives
IL148167A0 (en)	2002-09-12	Amino-triazolopyridine derivatives
GC0000183A (en)	2006-03-29	3-Phenyl-pyridine derivatives
GC0000338A (en)	2007-03-31	5-Phenyl-pyrimidine derivatives
IL145739A0 (en)	2002-07-25	13-methyl-erythromycin derivatives
IL148058A0 (en)	2002-09-12	Substituted 2-dialkylaminoalkylbiphenyl derivatives
IL148837A0 (en)	2002-09-12	Isoxazolecarboxamide derivatives
EG23070A (en)	2004-02-29	Novel propargylether derivatives
GC0000191A (en)	2006-03-29	4-Phenyl-pyrimidine derivatives
GC0000256A (en)	2006-11-01	Ethanesulfonyl-piperidine derivatives
GB9925880D0 (en)	1999-12-29	B-Carboline derivatives
IL150132A0 (en)	2002-12-01	Cyclopenteneone derivatives
IL147636A0 (en)	2002-08-14	3-amino-2-benzyl-1-phenyl-propane derivatives
AP2001002327A0 (en)	2001-12-31	1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
IL147494A0 (en)	2002-08-14	Benzofuran derivatives
PL351407A1 (en)	2003-04-22	Thio-oxindole derivatives
IL144045A0 (en)	2002-04-21	Oxetanone derivatives
AU1347601A (en)	2001-05-14	Oxetanone derivatives
AU6030000A (en)	2001-01-22	5-nitrofurfural derivatives
SI1222183T1 (en)	2003-10-31	Benzopyran derivatives
GB9907134D0 (en)	1999-05-19	Antimor napthylcombretastatin derivatives
IL146282A0 (en)	2002-07-25	Thio-oxindole derivatives
SI1178984T1 (en)	2003-08-31	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
SI1200445T1 (en)	2004-02-29	Thienopyranecarboxamide derivatives
SI1226131T1 (en)	2004-04-30	Isoxazolecarboxamide derivatives